Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Christopher

Showing results (361-370 of 444) with videos related to

Pageof 45
Sort By:
Cell|August 26, 2023
Structure of the thrombopoietin-MPL receptor complex is a blueprint for biasing hematopoiesisNaotaka Tsutsumi, Zahra Masoumi, Sophie C James, et al.
Nature Biotechnology|October 2, 2019
In vivo molecular imaging for immunotherapy using ultra-bright near-infrared-IIb rare-earth nanoparticlesYeteng Zhong, Zhuoran Ma, Feifei Wang, et al.
Nature Biotechnology|December 13, 2024
A general system for targeting MHC class II-antigen complex via a single adaptable loopHaotian Du, Jingjia Liu, Kevin M Jude, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 2021
Tuning MPL signaling to influence hematopoietic stem cell differentiation and inhibit essential thrombocythemia progenitorsLu Cui, Ignacio Moraga, Tristan Lerbs, et al.
Nature Medicine|June 27, 2018
A human anti-IL-2 antibody that potentiates regulatory T cells by a structure-based mechanismEleonora Trotta, Paul H Bessette, Stephanie L Silveria, et al.
American Journal of Human Genetics|January 9, 2008
X-linked dominant scapuloperoneal myopathy is due to a mutation in the gene encoding four-and-a-half-LIM protein 1Catarina M Quinzii, Tuan H Vu, K Christopher Min, et al.
Science (New York, N.Y.)|July 24, 2025
Design of high-specificity binders for peptide-MHC-I complexesBingxu Liu, Nathan F Greenwood, Julia E Bonzanini, et al.
The Journal of Experimental Medicine|October 5, 2023
TCR ligand potency differentially impacts PD-1 inhibitory effects on diverse signaling pathwaysWaipan Chan, Yuqi M Cao, Xiang Zhao, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2011
Although divergent in residues of the peptide binding site, conserved chimpanzee Patr-AL and polymorphic human HLA-A*02 have overlapping peptide-binding repertoiresMichael Gleimer, Angela R Wahl, Heather D Hickman, et al.
Biorxiv : the Preprint Server for Biology|January 27, 2025
IL-9 as a naturally orthogonal cytokine with optimal JAK/STAT signaling for engineered T cell therapyHua Jiang, Sam Limsuwannarot, Kayla R Kulhanek, et al.
Pageof 45

Showing results (361-370 of 444) with videos related to

Sort By:
Pageof 45
Cell|August 26, 2023
Structure of the thrombopoietin-MPL receptor complex is a blueprint for biasing hematopoiesisNaotaka Tsutsumi, Zahra Masoumi, Sophie C James, et al.
Nature Biotechnology|October 2, 2019
In vivo molecular imaging for immunotherapy using ultra-bright near-infrared-IIb rare-earth nanoparticlesYeteng Zhong, Zhuoran Ma, Feifei Wang, et al.
Nature Biotechnology|December 13, 2024
A general system for targeting MHC class II-antigen complex via a single adaptable loopHaotian Du, Jingjia Liu, Kevin M Jude, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 2021
Tuning MPL signaling to influence hematopoietic stem cell differentiation and inhibit essential thrombocythemia progenitorsLu Cui, Ignacio Moraga, Tristan Lerbs, et al.
Nature Medicine|June 27, 2018
A human anti-IL-2 antibody that potentiates regulatory T cells by a structure-based mechanismEleonora Trotta, Paul H Bessette, Stephanie L Silveria, et al.
American Journal of Human Genetics|January 9, 2008
X-linked dominant scapuloperoneal myopathy is due to a mutation in the gene encoding four-and-a-half-LIM protein 1Catarina M Quinzii, Tuan H Vu, K Christopher Min, et al.
Science (New York, N.Y.)|July 24, 2025
Design of high-specificity binders for peptide-MHC-I complexesBingxu Liu, Nathan F Greenwood, Julia E Bonzanini, et al.
The Journal of Experimental Medicine|October 5, 2023
TCR ligand potency differentially impacts PD-1 inhibitory effects on diverse signaling pathwaysWaipan Chan, Yuqi M Cao, Xiang Zhao, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2011
Although divergent in residues of the peptide binding site, conserved chimpanzee Patr-AL and polymorphic human HLA-A*02 have overlapping peptide-binding repertoiresMichael Gleimer, Angela R Wahl, Heather D Hickman, et al.
Biorxiv : the Preprint Server for Biology|January 27, 2025
IL-9 as a naturally orthogonal cytokine with optimal JAK/STAT signaling for engineered T cell therapyHua Jiang, Sam Limsuwannarot, Kayla R Kulhanek, et al.
Pageof 45